CRSP - Crispr Therapeutics AG - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - CRSP (1674416)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
30 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-07-06
CRSPBolzon Bradley J PhdDirS - Sale$82.39-20,0004,163,0640%-$1,647,730
2020-07-01
CRSPNovak RodgerPresS - Sale$80.00-50,000648,007-7%-$4,000,000
DM
2020-06-24
CRSPKlein Lawrence OttoCBO, COOS - Sale+OE$75.88-70,00020,000-78%-$5,311,564
2020-06-23
CRSPNovak RodgerPresS - Sale$75.00-50,000698,007-7%-$3,750,000
M
2020-06-22
CRSPBolzon Bradley J PhdDirS - Sale$73.93-20,0004,183,0640%-$1,478,522
M
2020-06-22
CRSPHo Tony WEVP, Head of R, DS - Sale$75.04-7,15833,747-17%-$537,123
D
2020-06-01
CRSPKulkarni SamarthCEOS - Sale+OE$64.68-17,275170,747-9%-$1,117,266
M
2020-05-22
CRSPNovak RodgerPresS - Sale$70.20-50,000748,007-6%-$3,510,020
M
2020-05-22
CRSPHo Tony WEVP, Head of R, DS - Sale$70.13-6,70040,905-14%-$469,884
2020-05-19
CRSPNovak RodgerPresS - Sale$65.00-50,000798,007-6%-$3,250,000
DM
2020-05-19
CRSPKulkarni SamarthCEOS - Sale+OE$65.25-15,000171,526-8%-$978,683
D
2020-05-11
CRSPKlein Lawrence OttoCBO, COOS - Sale+OE$60.40-25,00020,000-56%-$1,509,971
2019-11-19
CRSPBolzon Bradley J PhdDirS - Sale$67.41-42,0004,205,615-1%-$2,831,388
D
2019-11-19
CRSPNovak RodgerPresS - Sale+OE$70.00-33,6180-100%-$2,353,260
D
2019-11-19
CRSPCagnoni Pablo JDirS - Sale+OE$62.00-7,5000-100%-$465,000
D
2019-11-12
CRSPCagnoni Pablo JDirS - Sale+OE$55.00-7,5000-100%-$412,500
D
2019-10-30
CRSPCagnoni Pablo JDirS - Sale+OE$52.00-7,5000-100%-$390,000
2019-10-30
CRSPBolzon Bradley J PhdDirS - Sale$51.89-21,0004,247,6150%-$1,089,675
DM
2019-07-10
CRSPKlein Lawrence OttoChief Business OfficerS - Sale+OE$50.02-20,00020,000-50%-$1,000,353
2019-07-10
CRSPNovak RodgerPresS - Sale$50.00-50,000848,007-6%-$2,500,065
D
2019-06-17
CRSPKulkarni SamarthCEOS - Sale+OE$46.00-20,000165,801-11%-$920,000
2019-06-10
CRSPNovak RodgerPresS - Sale$45.00-50,000898,007-5%-$2,250,000
D
2019-04-29
CRSPKulkarni SamarthCEOS - Sale+OE$42.03-20,000166,542-11%-$840,600
M
2019-03-01
CRSPNovak RodgerPresS - Sale$40.40-85,220948,007-8%-$3,443,037
2019-02-25
CRSPNovak RodgerPresS - Sale$40.00-14,7801,033,227-1%-$591,233
A
2018-12-18
CRSPEmster Kurt VonDirS - Sale$29.70-62,9251,171,268-5%-$1,869,168
M
2019-01-08
CRSPNovak RodgerPresS - Sale$35.02-100,0001,048,007-9%-$3,502,385
M
2018-12-26
CRSPVertex Pharmaceuticals (Europe) Ltd10%P - Purchase$24.93+40,1985,380,940+1%+$1,002,194
M
2018-12-21
CRSPVertex Pharmaceuticals (Europe) Ltd10%P - Purchase$24.08+90,7425,340,742+2%+$2,184,960
M
2018-12-17
CRSPEmster Kurt VonDirS - Sale$29.85-72,9341,164,268-6%-$2,176,898
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top